Page 2

Tenaya Therapeutics takes in $106m
GV returned to help heart disease drug developer Tenaya boost its overall funding to approximately $248m.
Oxular eyes $37m round
Hovione Scientia and Consort Medical-backed Oxular has secured funding that will support phase 2 trials for a treatment for diabetic macular oedema.
Carisma charms its way to $59m
Penn Medicine contributed to a $12m extension for the cancer immunotherapy developer's series B round, which already inlcuded Livzon, Merck & Co and AbbVie.
CorPower uncorks new funding
Midroc Europe led a round that increzased the wave energy technology developer's total equity funding to $25m.
Armorblox stocks up with $30m
Siemens' Next47 unit led a series B round for the email security platform developer, increasing its total funding to more than $46m.
PharmEasy sells stake to CDPQ
The pension fund will pay an undisclosed sum for a 2% stake in API Holdings, the owner of online drugstore PharmEasy backed by Ascent Health and Medi Assist.
Skydio soars with $170m
Siemens’ Next47 subsidiary has returned to back the unmanned aerial vehicle technology producer’s latest round, valuing it above $1bn.
BetterUp bags $125m
Salesforce Ventures helped the professional coaching services provider push its valuation past $1.7bn in its series D round.
Newsela nets $100m in series D round
New and returning investors participated in the Kaplan-backed educational content provider’s latest round, which boosted its overall funding to $170m.
Xilio seals $95m series C round
Returning corporate investors Takeda Ventures and MRL Ventures Fund helped the cancer immunotherapy developer take its total funding to over $225m.

test reg